A carregar...
Donepezil can improve daily activities and promote rehabilitation for severe Alzheimer’s patients in long-term care health facilities
BACKGROUND: Cholinesterase inhibitors can delay the progression of Alzheimer’s disease (AD). Several clinical trials of the drug in moderate to severe AD have consistently reported clinically positive effects. A combining effect with psychosocial intervention was reported in mild to moderate AD pati...
Na minha lista:
| Publicado no: | BMC Neurol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4280048/ https://ncbi.nlm.nih.gov/pubmed/25516360 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-014-0243-7 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|